Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05867667 · ClinicalTrials.gov registry record · NA
Cardiac Rehabilitation to Improve Breast Cancer Outcomes
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT05867667 is a NA study that was terminated before completion, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 4 participants.
The verdict
NCT05867667, a NA study, was terminated before completion, sponsored by University of Michigan Rogel Cancer Center.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
To develop a novel, proactive cardiac rehabilitation program for breast cancer survivors at enhanced risk of cardiovascular disease. Considering this program is secondary to the Michigan Medicine Cardiac Rehabilitation program's goal to manage cardiac patients, the hybrid program has been designed that limits utilization of cardiac rehabilitation to 12 visits over the first eight weeks of the intervention compared to 32 visits for cardiovascular patients.
Interventions
- OTHER Cardiac Rehab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2024-03-19 |
| Est. Completion | 2024-08-13 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05867667
The ClinicalTrials.gov registry entry for NCT05867667 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cardiac Rehab is the first listed.
NCT05867667 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05867667 about?
NCT05867667 is a clinical study titled "Cardiac Rehabilitation to Improve Breast Cancer Outcomes". To develop a novel, proactive cardiac rehabilitation program for breast cancer survivors at enhanced risk of cardiovascular disease. Considering this program is secondary to the Michigan Medicine Cardiac Rehabilitation program's goal to manage cardiac patients, the hybrid program has been designed t...
What is the current status of trial NCT05867667?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2024-03-19. Estimated completion is 2024-08-13.
What interventions are being tested in trial NCT05867667?
The interventions under investigation include: Cardiac Rehab (OTHER).
Who is sponsoring clinical trial NCT05867667?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.